profeetM schreef op 10 april 2024 15:35:
The PLGA market is projected to reach USD 321 million by 2030, at a CAGR of 16.6% from USD 125 million in 2024. The market growth is driven by influencing factors such as government initiatives and regulations and exceptional biodegradability and biocompatibility nature.
The key global players in the PLGA market include Evonik (Germany), Corbion NV (Netherlands), Ashland (US), Mitsui Chemicals (Japan), Jinan Digang Bioengineering Co., Ltd. (China), Merck (Germany), Akina, Inc. (US), Nomisma Healthcare Pvt. Ltd. (India), Bezwada Biomedical, LLC (US), CD Bioparticles (US) are the key players in the PLGA market. These companies are strong in their home region and explore geographic diversification alternatives to grow their businesses. They focus on increasing their market shares through new product launches and other expansions.
To know about the assumptions considered for the study download the pdf brochure
Evonik
Evonik is one of the global leading specialty chemical companies. The company operates under 6 divisions: Specialty additives, Nutrition & Care, Smart Materials, Performance Materials, Technology & Infrastructure, Enabling Functions, and Others. It offers polylactic co-glycolic acid (PLGA) under the specialty nutrition & care segment. The company manufactures PLGA under the brand names “Lactel” and “Resomer”. These brands have strong records for safety and timely delivery of complex parenteral drug products. The biodegradable polymers offered by Evonik are available with either acid or esters end groups. The company serves its products to various end-use industries such as paint & coatings, agriculture, construction, plastics, rubber, pharmaceuticals, paper & printing, electrical & electronics, consumer & personal care products, and many others. The company has a global presence, operates in more than 100 countries, and 84% of sales are generated outside Germany. The production capacities are in Germany, Belgium, the USA, China, and Singapore.
Corbion NV
Corbion is a global leader in providing sustainable ingredient solutions. The company operates under 4 business segments, namely, sustainable food solutions, lactic acid & specialties, algae ingredients, and non-core activities. The company’s product line includes antioxidants, biochemical products, biomedical products, chemical products, pharma products, bioplastic products, and many others. The company provides PLGA under the brand “PURASORB”. Corbion offers high-quality PLGA polymers for precise dosages over extended periods, manufactured in advanced facilities and recognized as safe by regulatory agencies such as the FDA.
The company markets its products through a worldwide network of sales offices and distributors and has a global supply chain with manufacturing facilities in the US, Thailand, Brazil, Mexico, the Netherlands, and Spain.
Beide bedrijven komen elkaar tegen in verschillende deelmarkten. Uitgezocht wordt, of dit een mogelijk samengaan in de weg staat.